TMCnet News

Clinical Trial Advertising Agency, Clinical Trial Media, Discusses How To Track Patient Progress and Activity During Pharmaceutical Clinical Trials
[March 05, 2019]

Clinical Trial Advertising Agency, Clinical Trial Media, Discusses How To Track Patient Progress and Activity During Pharmaceutical Clinical Trials


HAUPPAUGE, N.Y., March 5, 2019 /PRNewswire/ -- Clinical trial management is a complex process and it's integral to ensure that the data captured during the process is tracked and stored properly for analysis. Many clinical trials have been turning to emerging technology that digitizes patient progress and activity. Clinical trial advertising agency, Clinical Trial Media, discusses how to track patient progress and activity during pharmaceutical clinical trials.

In all Phase I and Phase II clinical trials, clinical monitoring is required by both national and international agencies such as the National Institutes of Health and the World Health Organization. These administrative efforts and oversight track a patient's health and progress while participating in the clinical trial. The level of scrutiny used in these monitoring plans is dependent on several factors including the complexity of the trial, the risk of the treatment, the disease being evaluated and several other unique factors to the trial. As each trial has a unique set of patients, monitoring plans will vary from one trial to the next.

Clinical trials are beginning to move away from the traditional hard copy documentation process and have begun utilizing digital tools to help streamline the process and have more accessibility to patient data. Tracking ptients' status and condition in between visits used to be difficult, but with wearable technology/digital monitoring tools, data is captured in real-time and electronically stored so it's accessible to the clinical trial staff to manage and analyze at all times.



Our bodies are generating data at all times and usually, this data is only recorded once a year during routine check-ups. Bridging the data gap between visits can help give clinical trial staff members insight that was never previously available to them. It's likely that this constantly generated medical data will increase accuracy, efficiency, timing of trials as well as optimize costs.

As the wearable field grows, it's important to be mindful of privacy concerns that patients may have. Despite good intentions from the clinical trial staff, some patients may be uncomfortable with the idea of giving anyone 24/7 access and monitoring. As new technologies are developed, clinical trial staff members will need to adjust their strategies and skill sets to effectively use these tools to collect and analyze patient-generated data.


For every clinical trial, a plan for patient monitoring must be created and executed by the staff. Emerging technologies such as wearables and digital monitoring tools have begun bridging the gap of patient data collection between visits, giving clinical trials a new opportunity for consistent data collection. As new digital health initiatives surface, see what types of tools you can use to improve your next clinical trial.

About CTM: CTM is a global patient recruitment and retention firm that provides customized product and service offerings to maximize your study's enrollment potential. With our flexible solutions, superior customer service and vast clinical trial experience around the world, Clinical Trial Media is your global enrollment connection.

Cision View original content:http://www.prnewswire.com/news-releases/clinical-trial-advertising-agency-clinical-trial-media-discusses-how-to-track-patient-progress-and-activity-during-pharmaceutical-clinical-trials-300805492.html

SOURCE Clinical Trial Media


[ Back To TMCnet.com's Homepage ]